drugset / Trial / NCT00320983

Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer

NCT00320983

Phase 1 Completed 11 enrolled University of New Mexico
Non-randomizedParallel-groupOpen-labelTreatment

Summary

A Phase I Study of Adjuvant Topotecan and Cisplatin with Concurrent Radiation Therapy for Advanced Cervical Cancer.

Timeline

Start
2002-03
Primary completion
2004-06
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified
Subject Topotecan Small molecule

Indications